MTWA Screening Improves Cost-Effectiveness Of ICD Implantation, Study Says
This article was originally published in The Gray Sheet
Executive Summary
Use of Microvolt T-wave alternans to screen for ICD implantation in high-risk cardiac patients costs about $50,000 per quality-adjusted life year (QALY), according to a new study
You may also be interested in...
Physicians Weigh Benefits, Hurdles Of ICD Risk Stratification
Electrophysiologists hope that new risk stratification tools for sudden cardiac death can help sort out the most appropriate recipients of implantable cardioverter defibrillators, although barriers to adoption remain
CMS Expands ICD Coverage In Long-Awaited Decision; Stakeholders Rejoice
CMS' expansion of implantable cardioverter defibrillator Medicare coverage incorporates several recommendations from manufacturers and professional societies
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.